Exercise could reduce bone tumor growth

May 7, 2013 by Anne Ju, Cornell University
Exercise could reduce bone tumor growth
3-D microCT reconstructions of control and tumor-injected tibiae, loaded and nonloaded. Credit: Fischbach lab

(Medical Xpress)—Weight-bearing exercise, often prescribed to combat bone loss, might have anti-cancer effects. Cornell biomedical researchers report that mechanical stimulation of cancerous bone, in making bone stronger, seems to make tumors weaker.

The study, which involved both animal and in vitro models, showed that causing bone to bear moderate, repeated weight – akin to an – led to inhibited growth of bone tumors composed of metastasized breast cancer cells. The researchers think that such might reduce the expression of genes that interfere with normal, healthy bone functioning.

Published online May 3 by the Journal of Bone and Mineral Research, the study was led by first author and Maureen Lynch and senior author Claudia Fischbach-Teschl, associate professor of biomedical engineering.

Breast cancer often metastasizes to bone, which then deteriorates because a tumor disturbs the normal process of bone remodeling. The subsequent bone loss, which is caused by too much known as osteolysis, helps feed the tumor, because the bone is a depot of factors that promote . Degraded bone releases these stored factors, and the tumor grows.

The researchers used a bone "loading model" to show that tumors respond to mechanical stimulation. The loading model originated in the lab of paper co-author Marjolein van der Meulen, the Swanson Professor of Biomedical Engineering at Cornell, who studies biological mechanics particularly in bone.

The experiments showed that loading of a mouse tibia injected with malignant – recreating the metastatic condition – kept the tumor from growing and increased bone mass. Doing nothing allowed the tumor to proliferate and the bone to degrade.

Exercise could reduce bone tumor growth
Corresponding histologic cross-sections of tibiae that reveal that nonloaded tumor-bearing tibiae exhibit osteolytic degradation and extensive tumor formation, whereas loading inhibited these changes. Credit: Fischbach lab

"If you think about typical cancer treatment, like chemotherapies, they are targeting the cancer cells," Lynch said. "So we needed to figure out if loading is affecting the tumor cells in addition to the bone cells, or if this is some kind of indirect effect. We found a little bit of both."

To control microenvironmental factors, the researchers did other experiments with a 3-D tumor model designed in Fischbach-Teschl's lab. They injected tumor cells into a porous scaffold that looks like an aspirin pill, then loaded the cells by using a piston to squeeze the scaffold. They examined how different genes characteristic of tumor cells were expressed as the loading occurred.

Genes involved in cancer were largely unaffected, except one, called Runx2, a transcription factor that regulates gene expression and production of other proteins. This, in turn, affects what bone cells are doing.

In a cancer cell, the researchers have theorized, Runx2 directs the cells to secrete proteins that stimulate osteolysis, too much of which leads to bone loss. Mechanical loading inhibits expression of Runx2, and they think that's why proteins that affect osteolysis are also reduced. Further experimentation to confirm this theory is needed.

The insights from this paper could lead not only to drug therapies but also to more targeted exercise regimens for cancer patients, Fischbach-Teschl said.

"Specifically, physically mediated mechanisms in bone might be contributing to bone loss in cancer patients," she said. "So harnessing those things better is what could really help patients."

The paper is titled "In Vivo Tibial Compression Decreases Osteolysis and Tumor Formation in Human Metastatic Model."

Explore further: Heparin-like compounds inhibit breast cancer metastasis to bone

More information: onlinelibrary.wiley.com/doi/10 … jbmr.1966/references

Related Stories

Heparin-like compounds inhibit breast cancer metastasis to bone

May 21, 2012
Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a ...

'Fertilizing' bone marrow helps answer why some cancers spread to bones

May 15, 2012
Researchers found that administering a common chemotherapy drug before bone tumors took root actually fertilized the bone marrow, enabling cancer cells, once introduced, to seed and grow more easily.

Recommended for you

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

FDA approves first drug for tumors tied to breast cancer genes

January 12, 2018
(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.

Breast cancer gene does not boost risk of death: study

January 12, 2018
Young women with the BRCA gene mutation that prompted actress Angelina Jolie's pre-emptive and much-publicised double mastectomy are not more likely to die after a breast cancer diagnosis, scientists said Friday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.